Scios Inc.

Overview

Scios Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of treatments for cardiovascular and inflammatory diseases. As a subsidiary of Johnson & Johnson, Scios leverages state-of-the-art technology to advance clinical programs aimed at improving patient outcomes.

Therapeutic areas

API / Drug Master Files

Scios Inc. holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FIBLAST TRAFERMIN FOR INJECTION (RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH FACTOR, RHBFGF)Inactive1996-08-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Scios Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.